OM:ADDV B

Stock Analysis Report

Executive Summary

ADDvise Group AB (publ), through its subsidiaries, develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden and internationally.


Snowflake Analysis

Reasonable growth potential and fair value.

Share Price & News

How has ADDvise Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ADDV B has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

16.7%

ADDV B

-0.7%

SE Medical Equipment

1.4%

SE Market


1 Year Return

40.9%

ADDV B

23.1%

SE Medical Equipment

24.1%

SE Market

Return vs Industry: ADDV B exceeded the Swedish Medical Equipment industry which returned 23.1% over the past year.

Return vs Market: ADDV B exceeded the Swedish Market which returned 24.1% over the past year.


Shareholder returns

ADDV BIndustryMarket
7 Day16.7%-0.7%1.4%
30 Day16.7%-2.5%4.0%
90 Day11.3%4.0%12.1%
1 Year40.9%40.9%25.6%23.1%29.0%24.1%
3 Year-57.8%-57.8%54.7%36.6%39.8%18.7%
5 Yearn/a40.9%17.4%48.2%16.8%

Price Volatility Vs. Market

How volatile is ADDvise Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is ADDvise Group undervalued compared to its fair value and its price relative to the market?

43.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ADDV B (SEK0.84) is trading below our estimate of fair value (SEK1.47)

Significantly Below Fair Value: ADDV B is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ADDV B is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: ADDV B is unprofitable, so we can't compare its PE Ratio to the Swedish market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ADDV B's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ADDV B is good value based on its PB Ratio (1.3x) compared to the SE Medical Equipment industry average (4.6x).


Next Steps

Future Growth

How is ADDvise Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

114.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ADDV B is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (-0.4%).

Earnings vs Market: ADDV B is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ADDV B's is expected to become profitable in the next 3 years.

Revenue vs Market: ADDV B's revenue (8.5% per year) is forecast to grow faster than the Swedish market (4.7% per year).

High Growth Revenue: ADDV B's revenue (8.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ADDV B's Return on Equity is forecast to be low in 3 years time (9.6%).


Next Steps

Past Performance

How has ADDvise Group performed over the past 5 years?

21.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ADDV B is currently unprofitable.

Growing Profit Margin: ADDV B is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ADDV B is unprofitable, but has reduced losses over the past 5 years at a rate of 21.4% per year.

Accelerating Growth: Unable to compare ADDV B's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ADDV B is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.8%).


Return on Equity

High ROE: ADDV B has a negative Return on Equity (-0.52%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is ADDvise Group's financial position?


Financial Position Analysis

Short Term Liabilities: ADDV B's short term assets (SEK125.2M) exceed its short term liabilities (SEK114.4M).

Long Term Liabilities: ADDV B's short term assets (SEK125.2M) do not cover its long term liabilities (SEK162.5M).


Debt to Equity History and Analysis

Debt Level: ADDV B's debt to equity ratio (242.6%) is considered high.

Reducing Debt: ADDV B's debt to equity ratio has reduced from 263.3% to 242.6% over the past 5 years.


Balance Sheet

Inventory Level: ADDV B has a low level of unsold assets or inventory.

Debt Coverage by Assets: ADDV B's debt is not covered by short term assets (assets are 0.6x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ADDV B has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if ADDV B has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is ADDvise Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.6%markettop25%4.1%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate ADDV B's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ADDV B's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ADDV B's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ADDV B's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ADDV B's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

Rikard Akhtarzand (47yo)

kr2,762,000

Compensation

Mr. Richard Akhtarzand, also known as Rikard, serves as the Chief Executive Officer, President and Director of ADDvise Group AB (publ). Mr. Akhtarzand serves as Chief Executive Officer and Director at Kivs ...


CEO Compensation Analysis

Compensation vs Market: Rikard's total compensation ($USD280.97K) is above average for companies of similar size in the Swedish market ($USD205.08K).

Compensation vs Earnings: Rikard's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Richard Akhtarzand
CEO, President & Director0yrskr2.76m5.82% SEK4.9m
Aaron Wong
Chief Financial Officer1.3yrsno datano data
Erland Pontusson
Chief Operating Officer3.7yrsno data0.12% SEK101.6k
Tina Vasiliou
Legal Counsel1.1yrsno datano data
Nils Berglund
Senior Vice President0yrsno datano data
Johan Eklund
Chief Auditor4.8yrsno datano data
Astrid Möller
Head of Project Management & Service0yrsno datano data
Mats Andersson
Sales Manager of Laboratory Furniture & Safety Ventilation5.1yrsno datano data
Anders Elf
Consultant4.8yrsno datano data

4.3yrs

Average Tenure

43.5yo

Average Age

Experienced Management: ADDV B's management team is considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 70.4%.


Top Shareholders

Company Information

ADDvise Group AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ADDvise Group AB (publ)
  • Ticker: ADDV B
  • Exchange: OM
  • Founded: 1989
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr83.693m
  • Shares outstanding: 96.91m
  • Website: https://www.addvisegroup.se

Number of Employees


Location

  • ADDvise Group AB (publ)
  • Grev Turegatan 3
  • Floor 4
  • Stockholm
  • Stockholm County
  • 114 46
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ADDV AOM (OMX Nordic Exchange Stockholm)YesClass A SharesSESEKDec 2004
ADDV BOM (OMX Nordic Exchange Stockholm)Class B SharesSESEKSep 2015

Biography

ADDvise Group AB (publ), through its subsidiaries, develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden and internationally. The company’s Lab business unit offers laboratory furnishings, safety ventilation products, climate rooms, clean rooms, and laboratory apparatus. Its Healthcare business unit provides medical devices and consumable materials, including defibrillators and chairs for use in the urology and gynecology areas, as well as surgical tables for medical care. The company was formerly known as ADDvise Lab Solutions AB (publ) and changed its name to ADDvise Group AB (publ) in September 2015. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/20 23:01
End of Day Share Price2020/02/20 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.